GLPwatch
Papers (10378)
Page 98 of 173, ranked by citation count.
- Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.
- Weight Loss Efficacy of Tirzepatide Compared to Placebo or GLP-1 Receptor Agonists in Adults With Obesity or Overweight: A Meta-Analysis of Randomized Controlled Trials With ≥ 20 Weeks Treatment Duration.
- Impact of diabetes duration on achieved reductions in glycated haemoglobin, fasting plasma glucose and body weight with liraglutide treatment for up to 28 weeks: a meta-analysis of seven phase III trials.
- Effect of GLP-1 receptor agonists on body composition.
- Effectiveness of Adjuvant Semaglutide Following Bariatric Metabolic Surgery.
- The enduring metabolic improvement of combining dual amylin and calcitonin receptor agonist and semaglutide treatments in a rat model of obesity and diabetes.
- Pituitary Adenlylate Cyclase Activating Peptide Protects Adult Neural Stem Cells from a Hypoglycaemic milieu.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity.
- Changes in health-related quality of life with intensive behavioural therapy combined with liraglutide 3.0 mg per day.
- Targeting microglial GLP1R in epilepsy: A novel approach to modulate neuroinflammation and neuronal apoptosis.
- GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis.
- Fixed-Ratio Combinations of Basal Insulin and GLP-1RA in the Management of Type 2 Diabetes Mellitus: Highlights from the Literature.
- Activation of the renal GLP-1R leads to expression of <i>Ren1</i> in the renal vascular tree.
- [Exenatide stimulated solute-free water excretion by human kidney].
- Design, synthesis and biological evaluation of double fatty chain-modified glucagon-like peptide-1 conjugates.
- Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats.
- Controlling the uncontrolled variation in the diet induced obese mouse by microbiomic characterization.
- Advancements in the management of obesity: a review of current evidence and emerging therapies.
- Hot weight loss drugs tested against addiction.
- The effectiveness of 0.5 mg and 1mg of semaglutide in patients with type two diabetes and predictors of response: a retrospective cohort study.
- Tolerance Does Not Develop Toward Liraglutide's Glucose-Lowering Effect.
- GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond - New Insights 2015.
- Semaglutide May Ameliorate Fibrosis and Inhibit Epithelial-Mesenchymal Transition in Intrauterine Adhesion Models.
- A mouse model of weight gain after nicotine withdrawal.
- Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a".
- Changes in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes.
- Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical data.
- Treat to target in weight management with semaglutide: Real-world evidence from an eHealth clinic.
- Differential protective effects of exenatide, an agonist of GLP-1 receptor and Piragliatin, a glucokinase activator in beta cell response to streptozotocin-induced and endoplasmic reticulum stresses.
- Anti-diabetic properties of a non-conventional radical scavenger, as compared to pioglitazone and exendin-4, in streptozotocin-nicotinamide diabetic mice.
- Structure-Activity Relationships and Pharmacokinetics of <sup>111</sup>In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties.
- Letter to Editor. Re "de Leeuw SP, et al. Analysis of Serious Weight Gain in Patients Using Alectinib for ALK Positive Lung Cancer," Semaglutide a Potential Treatment for Serious Weight Gain From ALK Tyrosine Kinase Inhibitors?
- What the diabetologist needs to know about the risk of non-arteritic anterior ischaemic optic neuropathy and GLP-1 receptor agonist use in patients with type 2 diabetes.
- The effectiveness and value of tirzepatide for type 2 diabetes mellitus.
- Comparative Efficacy of Tirzepatide vs. Semaglutide in Reducing Body Weight in Humans: A Systematic Review and Meta-Analysis of Clinical Trials and Real-World Data.
- Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan.
- Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [<sup>68</sup>Ga]Ga-NODAGA-Exendin-4 Produced by a Fully Automated Method.
- EFFICACY AND SAFETY OF IDEGLIRA IN OLDER PATIENTS WITH TYPE 2 DIABETES.
- Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.
- Liraglutide promotes UCP1 expression and lipolysis of adipocytes by promoting the secretion of irisin from skeletal muscle cells.
- Sleeve Gastrectomy Versus Semaglutide for Weight Loss in a Severely Obese Minority Cohort: A Propensity-Matched Study.
- Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trial.
- Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis.
- GLP-1 agonists for people living with HIV and obesity, is there a potential?
- Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus.
- Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet.
- Liraglutide preserves intracellular calcium handling in isolated murine myocytes exposed to oxidative stress.
- Relative contribution of basal and postprandial hyperglycaemia stratified by HbA1c categories before and after treatment intensification with dulaglutide.
- Effect of the glucagon-like peptide-1 receptor agonists on diabetic peripheral neuropathy: A meta-analysis.
- Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis.
- Efficacy and Safety of Tirzepatide in Adults With Type 2 Diabetes: A Perspective for Primary Care Providers.
- GLP-1R knockdown abrogates the protective effects of liraglutide on ischaemic stroke via inhibition of M2 polarisation and activation of NLRP3 inflammasome by reducing Nrf2 activation.
- Palatable food avoidance and acceptance learning with different stressors in female rats.
- Liver paraoxonase 3 expression and the effect of liraglutide treatment in a rat model of diabetes.
- Liraglutide and Renal Outcomes in Type 2 Diabetes.
- Real-World Comparison of Oral Versus Injectable Semaglutide for the Reduction of Hemoglobin A<sub>1C</sub> and Weight in Patients with Type 2 Diabetes.
- Cardiometabolic risk factors efficacy of semaglutide in the STEP program.
- Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy.
- Liraglutide provides neuroprotection by regulating autophagy through the AMPK-FOXO3 signaling pathway in a spinal contusion injury rat model.
- Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: A prospective pilot study.